Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 1
2019 3
2020 6
2021 7
2022 1
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Drug Safety and Relevant Issues in the Real-World.
Barbieri MA, Irrera N, Convertino I. Barbieri MA, et al. Among authors: convertino i. Pharmaceuticals (Basel). 2023 Dec 5;16(12):1689. doi: 10.3390/ph16121689. Pharmaceuticals (Basel). 2023. PMID: 38139815 Free PMC article.
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.
Tuccori M, Ferraro S, Convertino I, Cappello E, Valdiserra G, Blandizzi C, Maggi F, Focosi D. Tuccori M, et al. Among authors: convertino i. MAbs. 2020 Jan-Dec;12(1):1854149. doi: 10.1080/19420862.2020.1854149. MAbs. 2020. PMID: 33319649 Free PMC article.
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future.
Tuccori M, Convertino I, Ferraro S, Valdiserra G, Cappello E, Fini E, Focosi D. Tuccori M, et al. Among authors: convertino i. Expert Opin Drug Discov. 2021 Dec;16(12):1403-1414. doi: 10.1080/17460441.2021.1960819. Epub 2021 Jul 30. Expert Opin Drug Discov. 2021. PMID: 34304682 Free PMC article. Review.
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison.
Machado FLDS, Cañás M, Doubova SV, Urtasun MA, Marín GH, Osorio-de-Castro CGS, Albuquerque FC, Ribeiro TB, Pont L, Crisóstomo Landeros J, Roldán Saelzer J, Sepúlveda Viveros D, Acosta A, Machado Beltrán MA, Gordillo Alas LI, Orellana Tablas LA, Benko R, Convertino I, Bonaso M, Tuccori M, Kirchmayer U, Contreras Sánchez SE, Rodríguez-Tanta LY, Gutierrez Aures Y, Lin B, Alipour-Haris G, Eworuke E, Lopes LC. Machado FLDS, et al. Among authors: convertino i. Regul Toxicol Pharmacol. 2023 Oct;144:105485. doi: 10.1016/j.yrtph.2023.105485. Epub 2023 Sep 1. Regul Toxicol Pharmacol. 2023. PMID: 37659711
29 results